HEB, Hemispherx Biopharma (AMEX)NEW Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HEB, Hemispherx Biopharma (AMEX)NEW

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: drkaz	2/16/2015 11:52:08 AM
	of 857

Here's the link for Sunday night's "60 Minutes" episode titled: ZMapp and the fight against Ebola. If ZMapp works there is still the issue of manufacturing a significant quantity. And this provides a window of opportunity for companies like HEB to make some hay - IF they can get past their own production and scale-up issues. And this is an area where HEB may stand with a serious advantage over ZMapp. http://www.cbs.com/shows/60_minutes/video/fOV7DDE1I8I0v1Im_cRLiQ2231HBgozg/zmapp-and-the-fight-against-ebola/ My impression (just watched it via the 60-minutes website) is that it was a very fair & evenhanded presentation of the problems that all Ebola and anti-bioterrorist treatments have run into. And all 'orphan' diseases. There is no market for a treatment other than a Government or NGO source,.... thus research progress is slow, halting, and of a very low priority. And since Government sources of funding have been horribly slow, and everybody thinks 'it' should be done, but nobody wants to pay for 'it' - instead of getting ahead of a problem, we always have to play catch up when problems appear. It was a good news article though. And Mr. Simon was among those few who was actually consistently a good journalist.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next